- Home
- EYPT vs SWBI Comparison
EYPT vs SWBI Comparison
Compare EYPT & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- SWBI
- Stock Information
- Founded
- EYPT 1987
- SWBI 1852
- Country
- EYPT United States
- SWBI United States
- Employees
- EYPT N/A
- SWBI N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- SWBI Ordnance And Accessories
- Sector
- EYPT Industrials
- SWBI Industrials
- Exchange
- EYPT Nasdaq
- SWBI Nasdaq
- Market Cap
- EYPT 484.4M
- SWBI 429.0M
- IPO Year
- EYPT 2005
- SWBI N/A
- Fundamental
- Price
- EYPT $8.25
- SWBI $9.70
- Analyst Decision
- EYPT Strong Buy
- SWBI Buy
- Analyst Count
- EYPT 8
- SWBI 2
- Target Price
- EYPT $24.29
- SWBI $12.75
- AVG Volume (30 Days)
- EYPT 895.1K
- SWBI 287.9K
- Earning Date
- EYPT 05-07-2025
- SWBI 06-20-2025
- Dividend Yield
- EYPT N/A
- SWBI 5.36%
- EPS Growth
- EYPT N/A
- SWBI 16.02
- EPS
- EYPT N/A
- SWBI 0.66
- Revenue
- EYPT $56,042,000.00
- SWBI $493,046,000.00
- Revenue This Year
- EYPT N/A
- SWBI N/A
- Revenue Next Year
- EYPT N/A
- SWBI $3.86
- P/E Ratio
- EYPT N/A
- SWBI $14.68
- Revenue Growth
- EYPT 12.04
- SWBI N/A
- 52 Week Low
- EYPT $3.91
- SWBI $8.38
- 52 Week High
- EYPT $13.99
- SWBI $16.85
- Technical
- Relative Strength Index (RSI)
- EYPT 72.87
- SWBI 56.12
- Support Level
- EYPT $5.46
- SWBI $9.34
- Resistance Level
- EYPT $8.36
- SWBI $9.87
- Average True Range (ATR)
- EYPT 0.57
- SWBI 0.19
- MACD
- EYPT 0.24
- SWBI 0.01
- Stochastic Oscillator
- EYPT 96.21
- SWBI 73.85
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.